| T0 (baseline) |  | T1 (6 m*) | T2 (12 m*) | T3 (18 m*) | Responsible entity |
---|---|---|---|---|---|---|
Confirm inclusion/exclusion criteria | X | Â | Â | Â | Â | FP |
Written informed consent | X | Â | Â | Â | Â | FP |
Sociodemographic variables | X | Â | Â | Â | Â | FP |
Morbidity variables and drug treatment plan | X | Â | X | X | X | FP |
Randomization of FP´s |  | X |  |  |  | RU |
FP intervention (intervention group) | Â | X | Â | Â | Â | RT |
Patient intervention (intervention group) | Â | Â | X | X | X | FP |
Mortality | Â | Â | Â | X | X | RT/FP |
Hospitalizations | Â | Â | Â | X | X | RT/FP |
Functionality (WHODAS), falls, hip fractures | Â | Â | X | X | X | FP |
Use of health services | Â | Â | X | X | X | RT |
Quality of life | X | Â | Â | X | X | FP |
Usability, adhesion, satisfaction | Â | Â | X | Â | X | TG |
Costs | Â | Â | Â | Â | X | RT |